Narrow search
Showing 1 - 10 of 118
Cover Image
Differentiated management of GM diffusion in China: Further hampering the self-sufficiency in cereal production?
Fok, Michel; Liang, Weili; Wang, Guiyan; Wu, Yuhong - HAL - 2004
China is a big country in terms of biotech achievements. It is also a rare country demonstrating crop …
Persistent link: https://www.econbiz.de/10008793327
Cover Image
Taux de change réel et productivité en Chine
Jeanneney, Sylviane Guillaumont; Hua, Ping - HAL - 2011
This article investigates the impact that the appreciation and the stability of the real exchange rate in China between … 1993 and 2001 have exerted on productivity growth. We give theoretical arguments explaining the impact of the real exchange … rate on productivity via its effects either on efficiency growth or on technical progress. Then for the twenty-nine Chinese …
Persistent link: https://www.econbiz.de/10008805933
Cover Image
Persistence of innovation, technological change and quality-adjusted patents in the US Pharmaceutical industry
Duflos, Gautier - HAL - 2006
importance of small firms for the technological change in pharmaceuticals, and suggest that large firms may persist in using …
Persistent link: https://www.econbiz.de/10010750721
Cover Image
Catching up in pharmaceuticals: a comparative study of India and Brazil
Guennif, Samira; Ramani, Shyama - HAL - 2010
in essential sectors such as pharmaceuticals. At the outset, they shared some common features: a considerable period of …. However, over fifty years, India has had much more success in building indigenous capabilities in pharmaceuticals than Brazil …
Persistent link: https://www.econbiz.de/10011026144
Cover Image
Regulatory policy and the location of bio-pharmaceutical FDI in Europe
Koenig, Pamina; Macgarvie, Megan - HAL - 2009
This paper examines the relationship bewteen cross-country differences in drug price regulation and the location of biopharmaceutical Foreign Direct Investment (FDI) in Europe. We use a theoretically-grounded location-choice model and data on 294 investments initiated in 27 European countries...
Persistent link: https://www.econbiz.de/10008839538
Cover Image
Inefficiencies in the sale of ideas: theory and empirics
Allain, Marie-Laure; Henry, Emeric; Kyle, Margaret - HAL - 2011
The sale of ideas (e.g. through licensing) facilitates vertical specialization and the division of labor between research and development. This specialization can improve the overall efficiency of the innovative process. However, these gains depend on the timing of the sale: the buyer of an idea...
Persistent link: https://www.econbiz.de/10009368491
Cover Image
Management Tools for RetD Project Portfolios in Complex Organizations – the case of an international pharmaceutical firm
Bayart, Denis; Bonhomme, Yves; Midler, Christophe - HAL - 2000
Project Portfolio Management (PPM) is a growing issue in both professional and academic circles. The typology of Cooper et al. (1998) has pictured the variety of PPM formalized approaches into four types (financial, strategic, scoring and “bubble diagram”). While the use of formalized...
Persistent link: https://www.econbiz.de/10008791076
Cover Image
External referencing and pharmaceutical price negotiation
Mariñoso, Begoña Garcia; Jelovac, Izabela; Olivella, Pau - HAL - 2011
External referencing (ER) imposes a price cap for pharmaceuticals based on prices of identical products in foreign …
Persistent link: https://www.econbiz.de/10008793124
Cover Image
The birth of the congressional clinic
Godefroy, Raphaël - HAL - 2010
This paper investigates the impact of mortality in the districts/states represented in key congressional groups (i.e. committees, subcommittees, and parties) on the public investment in medical research in the US. I focus on National Institutes of Health (NIH) R01 grants awarded between...
Persistent link: https://www.econbiz.de/10010739063
Cover Image
Healthy aging versus demographic trends: the French case, estimated by markovian microsimulation methods
Thiébaut, Sophie; Armstrong, Andrew; Ventelou, Bruno - HAL - 2009
The Objective of this paper is to test the consequences of changes in health status of future cohorts of French elderly on healthcare expenditures. We value the precise effect of epidemiological and life expectancy changes on health expenditures for 2025 by using a markovian microsimulation...
Persistent link: https://www.econbiz.de/10008793682